Skip to main content
. 2015 Oct 17;6(39):42312–42321. doi: 10.18632/oncotarget.5994

Figure 4. One-way sensitivity analysis of the pooled ORs and 95% CI for HOXB13 p.Gly84Glu mutation, omitting each data set in the meta-analysis.

Figure 4